Similar articles

• Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat.

  Overton P, Elliott PJ, Hagan RM, Clark D. Overton P, et al. Eur J Pharmacol. 1992 Mar 17;213(1):165-6. doi: 10.1016/0014-2999(92)90251-x. Eur J Pharmacol. 1992. PMID: 1379929
• Specific agonists for neurokinin B receptors.

  Drapeau G, d'Orléans-Juste P, Dion S, Rhaleb NE, Regoli D. Drapeau G, et al. Eur J Pharmacol. 1987 Apr 29;136(3):401-3. doi: 10.1016/0014-2999(87)90313-x. Eur J Pharmacol. 1987. PMID: 3038572
• Characterization of neurokinin receptors in various isolated organs by the use of selective agonists.

  Dion S, D'Orléans-Juste P, Drapeau G, Rhaleb NE, Rouissi N, Tousignant C, Regoli D. Dion S, et al. Life Sci. 1987 Nov 16;41(20):2269-78. doi: 10.1016/0024-3205(87)90538-8. Life Sci. 1987. PMID: 2824947
• Pharmacological and biochemical evidence for multiple types of tachykinin NK2 receptors.

  Buck SH, Fanger BO, van Giersbergen PL. Buck SH, et al. Ann N Y Acad Sci. 1991;632:112-5. doi: 10.1111/j.1749-6632.1991.tb33099.x. Ann N Y Acad Sci. 1991. PMID: 1719859 Review. No abstract available.
• Receptors for substance P and related neurokinins.

  Regoli D, Drapeau G, Dion S, D'Orléans-Juste P. Regoli D, et al. Pharmacology. 1989;38(1):1-15. doi: 10.1159/000138512. Pharmacology. 1989. PMID: 2542998 Review.